B-228084:
Dec 28, 1987
A firm protested a National Cancer Institute (NCI) contract award for chemicals evaluation, contending that NCI: (1) applied evaluation criteria not specified in the solicitation; (2) delayed award until the awardee completed its facility; and (3) did not timely notify it of its exclusion from the competitive range. GAO held that: (1) safety considerations were reasonably related to the evaluation...